Quantitative analysis of the proteome - uab.edu 1-28-13.pdf · BMG 744 ProteomicsBMG 744...
Transcript of Quantitative analysis of the proteome - uab.edu 1-28-13.pdf · BMG 744 ProteomicsBMG 744...
1/27/2013
1
BMG 744 ProteomicsBMG 744 Proteomics--Mass Mass SpectrometrySpectrometry
Quantitative analysis of the proteome
Stephen Barnes, PhD
11/28/13
Proteomics Data Standards
• 2005 MCP ‐ Paris guidelines• 2008 HUPO – MIAPE (Minimum Information About a Proteomics Experiment) and mzML
• 2008 NCI ‐ Amsterdam principles– (1) timing, (2) comprehensiveness, (3) format, (4) deposition to repositories, (5) quality metrics, and (6) responsibility for proteomics data release.
• 2011 NCI – Sydney– For users of public data– Reviewers of journalsReviewers of journals– Multi‐site projects with unpublished data
• 2013 HUPO Proteomics Standards Initiative– http://www.psidev.info/
1/28/13 2
Kissinger et al MCP 10:1‐9, 2011
1/27/2013
2
Proteomics Data Standards
• Common descriptive terms• Sufficient experimental description• Sufficient experimental description• Data format• Data quality
– Mass accuracy (evidence of calibration)– Repeatability (technical and biological replicates)– False discovery rate (MRM and pseudoMRM)– Degeneracy of MRM– # of peptides to make a match
• Reference materials
1/28/13 3
Kissinger et al MCP 10:1‐9, 2011
Use of isotopesICAT (d /d ) and ICAT 13C /13C
Quantitative proteomics
– ICAT (do/d8) and ICAT 13C0/13C8
– d0/d10 propionic anhydride (N-terminal labeling)
– 15N/14N (whole cell labeling)– 18O/16O (trypsin)– iTRAQ labelingg
• Non-isotope methods– Peptide coverage– Classical triple quadrupole methods (MRM)
41/28/13
1/27/2013
3
Isotope-coded affinity technology
This reagent reacts with cysteine-containing proteins (80-85% of proteome)
Labeling can be replacement of hydrogens (X) with deuterium, or better to exchange 12C with 13C in the linker region (this avoids chromatography issues)
51/28/13
61/28/13
1/27/2013
4
Quantification from ESIQuantification from ESI--mass spectrummass spectrumSchmidt et al., Mol Cell Prot, 2003
71/28/13
Quantification with isotopicallylabeled amino acids
D3
1/28/13 8
1/27/2013
5
91/28/13
1/28/13 10
1/27/2013
6
Arginine‐13C/15N isotopic labeling
1/28/13 11
1/28/13 12
1/27/2013
7
1/28/13 13
Isotope labeling with 13C15N‐lysine
1/28/13 14
1/27/2013
8
1/28/13 15Brossier et al. unpublished
Verifying absorption of phosphoproteins onto IMAC
1/28/13 16Brossier et al. unpublished
1/27/2013
9
Inte
nsi
ty
DSVVAGFQWATK
H:L Ratio 0.8168
Elongation factor 2 OS=Homo sapiens GN=EEF2 PE=1 SV=4
ty
ILLAELEQLK
H:L Ratio 1.6427
1/28/13 17
Inte
nsit
Vimentin OS=Homo sapiens GN=VIM PE=1 SV=4
Brossier et al. unpublished
1818OO--labelinglabeling
• Trypsin catalyzes the transfer of 18O in 18O enriched water to both the carboxylate18O-enriched water to both the carboxylate oxygens of the C-terminus of tryptic peptides
R-COOH R-C18O2H
• The peptides have an increase in mass of 4 D4 Da
• Generally not considered a large enough mass difference
181/28/13
1/27/2013
10
Tandem mass tag reagents
• TMT reagents are isobaric, i.e., they have the same molecular weight and are chemicallysame molecular weight and are chemically the same, but their “parts” have different masses
• Some reagents have four parts:– A mass reporter (different for each reagent)
A l bl i– A cleavable region
– An isotopic balancing region
– A lysine‐NH2 reacting reagent
1/28/13 19
iTRAQ quantificationiTRAQ quantification• The iTRAQ™ reagents
React with Lys amino– React with Lys amino groups and each one adds 145 Da to the molecular weight of the peptide
– Fragmentation produces reporter ions from m/z 114, 115, 116 and 117and 117
– Current iTRAQ kit contains 8 forms with reporter fragment ions of m/z 114, 115, 116, 117, 118, 119 and 121
201/28/13
1/27/2013
11
iTRAQ™ Reagent Design
Amine specific
Charged Neutral loss
Isobaric Tag(Total mass = 145)
Reporter Balance PRG
• Gives strong signature ion in • Balance changes pg gMS/MS
• Gives good b- and y-ion series• Maintains charge state • Maintains ionization efficiency
of peptide• Signature ion masses lie in
quiet region
Balance changes in concert with reporter mass to maintain total mass of 145
• Neutral loss in MS/MS
Isobaric Tag(Total mass = 145)
= MS/MS Fragmentation SiteIsobaric Tag
Total mass = 145
PRG
Peptide Reactive Group
Reporter(Mass = 114 thru 117)
Balance(Mass = 31 thru 28)
Reporter Group mass114 –117 (Retains Charge)
Balance GroupMass 31-28 (Neutral loss)
Amine specific peptidereactive group (NHS)
N
N
O
O
N
O
O
Slide provided by Applied BiosystemsSlide provided by Applied Biosystems211/28/13
TMT reagent from Pierce
1/28/13 22
1/27/2013
12
A 6‐plex TMT reagent
1/28/13 23
MS/MS spectrum of TMT tags
Th f th t ti tid hThe mass of the tryptic peptide when reacted with anyone of the TMT reagents is the same.
However, each reagent gives a separate reporter mass (m/z 126, 127, 128, 129, 130 and 131.
Therefore samples from different
1/28/13 24
Therefore, samples from different experimental conditions can be combined and analyzed in a single run.
1/27/2013
13
Other nonOther non--isotopic quantitative isotopic quantitative methods in proteomicsmethods in proteomics
The coverage (the g (number of peptides observed for a protein) is sensitive to the amount of the protein– This can be used to
calculate whether a treatment affects th b d f
8401.3
30
40
50
60
70
80
90
100
% In
tens
ity
2452.171366.82
1494 90
2 peptides, 10 fmol
8401.3
30
40
50
60
70
80
90
100
% In
tens
ity
2452.171366.82
1494 90
7 peptides, 50 fmol
8401.3
30
40
50
60
70
80
90
100
% In
tens
ity
2452.171366.82
1494 90
10 peptides, 200 fmol
the abundance of a protein where fold-change > 2
– Applies to LC-MS (MUDPIT methods)
900 1520 2140 2760 3380 4000Mass (m/z)
00
10
20
30 1494.90
2646.331267.76 2164.052517.291388.78 2186.02 3141.451544.76
3163.46
900 1520 2140 2760 3380 4000Mass (m/z)
00
10
20
30 1494.90
2646.331267.76 2164.052517.291388.78 2186.02 3141.451544.76
3163.46
900 1520 2140 2760 3380 4000Mass (m/z)
00
10
20
30 1494.90
2646.331267.76 2164.052517.291388.78 2186.02 3141.451544.76
3163.46
251/28/13
This quote comes from the January 2013 issue of Nature Methods. It noted there are several q ymethods for measuring proteins (antibodies, immunofluorescence, protein arrays)
1/28/13 26
1/27/2013
14
Triple quad MRM analysisTriple quad MRM analysisPeptides of interest can be analyzed like small molecules
Collision gas
N2
Gas
Q1 Q2 Q3 Detector
‐++‐‐
‐‐
‐‐‐ ‐‐ ‐
Collision gasGasSamplesolution
5 KV
• Multiple reaction ion scanning
First filter the [M+nH]n+ precursor ion of the analyte (Q1)
Fragment the precursor ion with N gas (Q2)
• Multiple reaction ion scanning
First filter the [M+nH]n+ precursor ion of the analyte (Q1)
Fragment the precursor ion with N gas (Q2)Fragment the precursor ion with N2 gas (Q2)
Select a specific (and unique) product ion (Q3)
Measure ion current reaching the detector for 20-50 msec
Repeat with a precursor/product ion combination for another peptide, etc.
Fragment the precursor ion with N2 gas (Q2)
Select a specific (and unique) product ion (Q3)
Measure ion current reaching the detector for 20-50 msec
Repeat with a precursor/product ion combination for another peptide, etc.
271/28/13
Multiple reaction ion monitoring
Quantitative analysis of peptides in a complex mixture carried out using a triple
LCquadrupole instrument
1/28/13 28
Q1 Q2 Q3 DetectorIonizer
Based on precursor ion/product ion pair(s)Courtesy, John Cutts
1/27/2013
15
Flight path of ions through the quadrupoleion mass is higher than the set mass
1/28/13 29N Mueller
Flight path of ions through the quadrupoleion mass is lower than the set mass
1/28/13 30N Mueller
1/27/2013
16
Flight path of ions through the quadrupoleion mass is the same as the set mass
1/28/13 31N Mueller
The real quadrupole ions0.7 m/z wide
1/28/13 32N Mueller
1/27/2013
17
Quantitation experiment for Quantitation experiment for biotinylatedbiotinylated cytochrome c cytochrome c
MRM analysis monitored in 50 channelsMRM analysis monitored in 50 channels
4 5e5
1.0e5
2.0e5
3.0e5
4.0e5
4.5e5
11.47
2 4 6 8 10 12 14 16 18 20 22 24 26 28
Time, min
0.0
Each colored peak represents a different biotinylated peptide
331/28/13
Quantitative Accuracy: MyoglobinQuantitative Accuracy: Myoglobin
16
2D Gels Label FreeStable Isotope Labeling
14
A = 0.5 pmolB = 5 pmol
Color Indicates Method Used
iTRAQ
ICPL
ICATICAT
B/A Ratio
10
6
Anticipated Mole Ratio 10
14
12
8
18O Labeling
Label Free
Label Free + targeted SRM
2D-Gels (nonDIGE)
2D-DIGE
0
4
2
341/28/13
1/27/2013
18
MALDI‐TOF and nanoLC‐tandem MS
Gel‐LC for protein separation
Workflow for generation of proteomics data
MudPIT2D‐DIGE and other electrophoresis
Bioinformatics analysis
Signaling and protein complexes analysis
Microarray analysisBiological and
experimental knowledge
microRNA analysis
Quantitative MRM analysis
351/28/13
HIFHIF‐‐11 in kidney cytosol by LCin kidney cytosol by LC‐‐MRMMRM‐‐MSMS
361/28/13
1/27/2013
19
Multiple reaction ion monitoring of Krebs cycle enzymes
371/28/13
Splicing generates a new sequence at the junction between exon 4 and exon 6
Exon 4
1/28/13 38
Exon 6
1/27/2013
20
1/28/13 39
Lee FJ et al., 2011
Limitations of MRM‐MS
• A single precursor/product ion combination is not sufficiently specific (see class on MRMPath)sufficiently specific (see class on MRMPath)
– Need 3‐4 product ions to provide specificity
– This decreases the number of different peptides that can be monitored per second
• The quadrupole analyzer has a low mass accuracy
– Typically the peak is passed through a 0.7m/z filterTypically the peak is passed through a 0.7 m/z filter
• In an ideal world, we need an MS instrument that can collect high mass accuracy (2‐3 ppm) MSMS spectra in 20‐50 msec
1/28/13 40
1/27/2013
21
Pseudo MRM Analysis
Select PeptideDetect All Fragments
Fragment peptide
• High resolution TOF Analyzer for
Q1 Q2
1/28/13 41
• High resolution TOF Analyzer for detection of fragment ions TOF
Pseudo MRM Analysis
Select PeptideDetect All Fragments
Fragment peptide
• High resolution TOF Analyzer for
Q1 Q2
1/28/13 42
• High resolution TOF Analyzer for detection of fragment ions TOF
1/27/2013
22
Pseudo MRM Analysis
Select PeptideDetect All Fragments
Fragment peptide
• High resolution TOF Analyzer for
Q1 Q2
1/28/13 43
• High resolution TOF Analyzer for detection of fragment ions TOF
Pseudo MRM Analysis
Select PeptideDetect All Fragments
Fragment peptide
• High resolution TOF Analyzer for
Q1 Q2
1/28/13 44
• High resolution TOF Analyzer for detection of fragment ions TOF
1/27/2013
23
Pseudo MRM Analysis
Select PeptideDetect All Fragments
Fragment peptide
TOF MS/MS Spectrum
Q1 Q2
p
1/28/13 45
• The key difference between the TripleTOF and the triple quad is that the entire MSMS spectrum is collected by the TripleTOF in a single 50 sec (or shorter) data acquisition – the selection of product ion to follow is made post‐data acquisition
TOF
Summation of all MRM channels
Fragment intensities of individual ions derived from m/z677.4
y10
y9y8
y7
y6
626.3118
713.3464
y5
y4
363.2034
y3261.1557
y2
227.1751b2
b3Full MSMS spectrum
461/28/13
1/27/2013
24
Verifying and quantifying C‐truncation
• A crystallin is supposedly processed to a 173aa form from the 196aa translated product. Interestingly, what we see is the removal of an interior 23aa peptide, so it must be differential splicing, not posttranslational processingposttranslational processing.
• Processed rat A crystallin has a chymotrypsin cleavage site at 141Phe
• This peptide can be observed as a triply charged peptide
– FSGPKVQSGLDAGHSERAIPVSREEKPSSAPSS
• The C-truncations observed by mass spectrometry imaging are the following:
– SGPKVQSGLD (truncation at 151)
SGPKVQSGLDAGHSE (truncation at 156)
1/28/13 47
– SGPKVQSGLDAGHSE (truncation at 156)
– SGPKVQSGLDAGHSER (truncation at 157)
– SGPKVQSGLDAGHSERAIPVSR (truncation at 163)
– SGPKVQSGLDAGHSERAIPVSREEKPS (truncation at 168)
Fragmentation of a chymotrypticpeptide
NH2-SGPKVQSGLD-COOH[M+2H]2+ = 494.55
b-ions y-ionsb1 = - y1 = (134)b2 = 145 y2 = (247)b3 = 242 y3 = (304)b4 = 370 y4 = (391)b5 = 469 y5 = (519)b6 = 597 y6 = (618)6 y6 ( )b7 = 684 y7 = 746b8 = 741 y8 = 843b9 = 854 y9 = 900b10 = 969 y10 = 987
1/28/13 48
1/27/2013
25
16000
18000
8.5 9.0 9.5 10.0 10.5 11.0 11.5 12.0 12.5
Time, min
2000
4000
6000
8000
10000
12000
14000
Inte
nsi ty
DAY 21 Lens
DAY 50 Lens
DAY 100 Lens
XIC from I21 C.wiff (sample 1) - I21 C, Experiment 13, +TOF MS^2 of 524.8 (100 - 2000): 668.325 +/- 0.025 Da, Gaussian smoothedXIC from I50 C wiff (sample 1) I50 C Experiment 13 +TOF MS^2 of 524 8 (100 2000): 668 325 +/ 0 025 Da Gaussian smoothed
XIC from I21 C.wiff (sample 1) - I21 C, Experiment 10, +TOF MS^2 of 461.8 (100 - 2000): 722.404 +/- 0.025 Da, Gaussian smoothedXIC from I50 C wiff (sample 1) - I50 C Experiment 10 +TOF MS^2 of 461 8 (100 - 2000): 722 404 +/- 0 025 Da Gaussian smoothed
SGPKVQSGLD
1‐151 aa. Truncation
1/28/13 498.5 9.0 9.5 10.0 10.5 11.0 11.5 12.0 12.5Time, min
0.0e0
5.0e3
1.0e4
1.5e4
2.0e4
2.5e4
3.0e4
Inte
nsi ty
Full Length αA‐Crystallin
SGPKVQSGLDAGHSERAIPVSREEKPSSAPSS
10.2 10.4 10.6 10.8 11.0 11.2 11.4 11.6 11.8 12.0 12.2 12.4 12.6 12.8 13.0 13.2 13.4 13.6 13.8Time, min
200
300
400
500
600
Inte
nsity
XIC from I50 C.wiff (sample 1) - I50 C, Experiment 13, +TOF MS^2 of 524.8 (100 - 2000): 668.325 +/- 0.025 Da, Gaussian smoothedXIC from I100 C.wiff (sample 1) - I100 C, Experiment 13, +TOF MS^2 of 524.8 (100 - 2000): 668.325 +/- 0.025 Da, Gaussian smoothed
α‐Tubulin Sample Control Peptide
APVISAEKAY
11.3 11.4 11.5 11.6 11.7 11.8 11.9 12.0 12.1 12.2 12.3 12.4 12.5 12.6 12.7Time, min
0
1000
2000
3000
4000
5000
6000
Inte
nsi ty
XIC from I50 C.wiff (sample 1) - I50 C, Experiment 10, +TOF MS 2 of 461.8 (100 - 2000): 722.404 +/- 0.025 Da, Gaussian smoothedXIC from I100 C.wiff (sample 1) - I100 C, Experiment 10, +TOF MS^2 of 461.8 (100 - 2000): 722.404 +/- 0.025 Da, Gaussian smoothed
Bovine Serum Albumin Loading Control Peptide:(1fmole/µl)
AEFVEVTK
1/28/13 50
1/27/2013
26
1/28/13 51
Concatenation Concatenation -- making making 1313CC--labeled peptide internal standardslabeled peptide internal standards
K
KC t tid
Splice together the individual oligo DNAs to
K
K
K
K
Convert peptide sequences to oligo DNA sequences
form a composite cDNA
Insert cDNA into a plasmid and
bi tlNH2- COOH
recombinantly express in bacteria in the presence of Lys-13C6
15N2
K*
K*K*
K*
K*
K*
Treat with trypsin
Anderson & Hunter, 2005521/28/13
1/27/2013
27
Quantitative peptide MRMQuantitative peptide MRM--MSMS
• The albumin-depleted plasma proteome is mixed with the composite 13C,15N-labeled protein i t l t d d d th t t d ith t iinternal standard and then treated with trypsin
• The molecular ions (doubly charged) and the specific y ions for each peptide and its labeled form are entered into the MRM script one channel at a time
• A single run may consist of 30 peptides in 60 channels
• Sensitivity is compromised by “sharing out”measurement time, but can be compensated for by carrying out nanoLC
531/28/13
The future – SWATH MS
• http://www.youtube.com/watch?v=VZAZtA_qEbEbg
• Data independent analysis with a mass spectrometer that has a fast enough analyzer (TOF) to allow comprehensive quantitative(TOF) to allow comprehensive quantitative analysis of ALL peptides that elute from a LC column
1/28/13 54
1/27/2013
28
References for these talks (1)• Flory MR, Griffin TJ, Martin D, Aebersold R. Advances in quantitative
proteomics using stable isotope tags. Trends in Biotechnology 20: S23, 2002.
• Ong SE Mann M Mass spectrometry-based proteomics turnsOng SE, Mann M. Mass spectrometry based proteomics turns quantitative. Nature Chemical Biology. 1:252-262, 2005.
• Gruhler A, Schulze WX, Matthiesen R, Mann M, Jensen ON. Stable isotope labeling of Arabidopsis thaliana cells and quantitative proteomics by mass spectrometry. Molecular & Cellular Proteomics. 4:1697-1709, 2005.
• Anderson L, Hunter CL. Quantitative Mass Spectrometric Multiple Reaction Monitoring Assays for Major Plasma Proteins. Molecular & Cellular Proteomics 5:573-588, 2006.
• Yao X, Freas A, Ramirez J, Demirev PA, Fenselau C. Proteolytic 18O labeling for comparative proteomics: model studies with two g p pserotypes of adenovirus. Analytical Chemistry 73, 2836-42, 2001.
• Wang G, Wu WW, Zeng W, Chou C-L, Shen R-F. Label-Free Protein Quantification Using LC-Coupled Ion Trap or FT Mass Spectrometry: Reproducibility, Linearity, and Application with Complex Proteomes. Journal of Proteome Research 5: 1214-1223, 2006.
551/28/13
Bibliography Bibliography (2)(2)• Beck M, Schmidt A, Malmstroem J, Claassen M, Ori A,
Szymborska A, Herzog F, Rinner O, Ellenberg J, Aebersold R. The quantitative proteome of a human cell line. Molecular Systems Biology 7: 549 (2011).
• Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M. Global quantification of mammalian gene expression control. Nature 473: 337-342 (2011).
• Picotti P, Bodenmiller B, Aebersold R. Proteomics meets the scientific method. Nat Methods. 10:24-7 (2011).
• Gillette MA, Carr SA. Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry. Nat Methods. 10:28-34 (2013).
1/28/13 56
Methods. 10:28 34 (2013). • Fonslow BR, Stein BD, Webb KJ, Xu T, Choi J, Park SK, Yates JR
3rd. Digestion and depletion of abundant proteins improves proteomic coverage. Nat Methods. 10:54-6 (2013).